Vaccinating against HIV has been a decades-long effort, stymied by the virus’s high mutation rate and mask of human glycans.
After decades of failed HIV vaccines, a new approach that predicts which cells to train, not just what antigen to show, has ...
An experimental HIV vaccine trained immune cells to generate broadly neutralizing HIV antibodies in primates. The findings ...
Researchers said an effective HIV vaccine would need to stimulate the immune system to produce neutralising antibodies.
A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...
A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists, and IAVI has the ...
Highlights:Scientists at La Jolla Institute for Immunology and Scripps Research have developed an HIV vaccine that trains immune cells to see past ...
Genetic profiles and the gene editor CRISPR threaten to bring a new eugenics of gene selection, but even eugenicist Foster ...
HIV can damage the brain and cause memory and cognitive problems. And once HIV enters the brain, it does not leave. HIV targets a type of immune cell called helper T cells. These immune cells move ...
Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives. However, a small portion of people experience detectable—and worrisome—traces of ...
In simple terms: a virus is a tiny package of genetic instructions with a delivery system. Outside a cell it is metabolically inert. Once inside a susceptible cell, it redirects the cell's machinery ...
CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV. A Miracle cancer therapy that involves engineering a patient’s own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results